Helsinn SA is a pharmaceutical group with an extensive portfolio of marketed cancer care products and a broad development pipeline. Since 1976, Helsinn, focused on the development of new treatments to fulfill more medical needs and on improving the everyday lives of patients, all guided and underpinned by core family values of respect, integrity and quality. The Group works across pharmaceuticals, biotechnology and medical devices and has expertise in research and development, manufacturing and commercialization of therapeutic and supportive care products for cancer, pain and inflammation and gastroenterology.